Attenuating Effect of Gossypol on Tumor Growth in Systemic Malignancies

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 1551-1552

  Kapoor, Shailendra ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GOSSYPOL;

ANIMAL; CHEMISTRY; DNA STRAND BREAKAGE; LETTER;

ANIMALS; DNA BREAKS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; GOSSYPOL;

EID: 84888391592     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9673-x     Document Type: Letter

References (10)

1. Senarisoy, M., Canturk, P., Zencir, S., Baran, Y., & Topcu, Z. (2013). Gossypol interferes with both Type I and Type II topoisomerase activities without generating strand breaks. Cell Biochemistry and Biophysics, 66(1), 199-204.
2. Ye, W., Chang, H. L., Wang, L. S., et al. (2010). Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells. International Journal of Molecular Medicine, 26, 113-119.
3. van Poznak, C., Seidman, A. D., Reidenberg, M. M., et al. (2001). Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial. Breast Cancer Research and Treatment, 66, 239-248.
4. Karaca, B., Atmaca, H., Uzunoglu, S., Karabulut, B., Sanli, U. A., & Uslu, R. (2009). Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7. Journal of the Balkan Union of Oncology, 14, 479-485.
5. Ye, W., Chang, H. L., Wang, L. S., et al. (2007). Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil. Anticancer Research, 27, 107-116.
6. Atmaca, H., Gorumlu, G., Karaca, B., et al. (2009). Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells. European Cytokine Network, 20, 121-130.
7. Sung, B., Ravindran, J., Prasad, S., Pandey, M. K., & Aggarwal, B. B. (2010). Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. Journal of Biological Chemistry, 285, 35418-35427.
8. Zhang, M., Liu, H., Tian, Z., Huang, J., Remo, M., & Li, Q. Q. (2007). Differential growth inhibition and induction of apoptosis by gossypol between HCT116 and HCT116/Bax(-/-) colorectal cancer cells. Clinical and Experimental Pharmacology and Physiology, 34, 230-237.
9. Gunassekaran, G. R., Priya, D. K., Gayathri, R., & Sakthisekaran, D. (2011). In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. Biochemical and Biophysical Research Communications, 411, 661-666.
10. Mohammad, R. M., Wang, S., Banerjee, S., Wu, X., Chen, J., & Sarkar, F. H. (2005). Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas, 31, 317-324.